Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
418.00
+7.25 (1.77%)
Sep 24, 2026, 11:55 AM IST
Gujarat Themis Biosyn Revenue
Gujarat Themis Biosyn had revenue of 437.90M INR in the quarter ending June 30, 2026, with 22.07% growth. This brings the company's revenue in the last twelve months to 1.74B, up 17.51% year-over-year. In the fiscal year ending March 31, 2026, Gujarat Themis Biosyn had annual revenue of 1.66B with 9.96% growth.
Revenue (ttm)
1.74B
Revenue Growth
+17.51%
P/S Ratio
30.72
Revenue / Employee
7.86M
Employees
221
Market Cap
53.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.66B | 150.23M | 9.96% |
| Mar 31, 2025 | 1.51B | -190.22M | -11.20% |
| Mar 31, 2024 | 1.70B | 214.37M | 14.45% |
| Mar 31, 2023 | 1.48B | 335.31M | 29.19% |
| Mar 31, 2022 | 1.15B | 242.91M | 26.82% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 50.04B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.09B |
| Indoco Remedies | 18.73B |
| Innova Captab | 17.49B |
| Solara Active Pharma Sciences | 14.31B |
| Windlas Biotech | 9.42B |
| Orchid Pharma | 8.52B |
Gujarat Themis Biosyn News
- 4 months ago - Gujarat Themis Biosyn shares jump 5% after signing Rs 1,300 crore deal to acquire Japan’s Microbiopharm entity - Business Upturn
- 11 months ago - Gujarat Themis Biosyn begins commercial production after major capacity expansion at Vapi facility - Business Upturn
- 1 year ago - Gujarat Themis Biosyn starts commercial production at new API plant in Vapi, Gujarat - Business Upturn
- 1 year ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn